From Preclinical Studies to Clinical Development: Building an Efficient Drug Development Strategy
Bringing a new therapy from the lab bench to the patient’s bedside remains one of the most complex, expensive, and time-consuming journeys in modern science. It typically takes 10–15 years and over a billion dollars to get a molecule from discovery to regulatory approval, with many candidates failing to reach this stage. However, sponsors can significantly shorten timelines, lower costs, and enhance clinical success by implementing an efficient and well-integrated development strategy from the outset. This blog outlines the stages of the preclinical-to-clinical journey, highlights common pitfalls that can delay programs, and discusses how a strategic framework, such as the one provided by CurexBio, can assist sponsors in accelerating their processes without compromising quality. The transition from preclinical research to clinical development is considered a challenging phase in drug development. It requires the conversion of promising laboratory data into a solid, regulator-comp...